Gila Internal Medicine is categorized under Internal Medicine Doctors in Tempe, AZ and active since 2002.
Gila Internal Medicine was established in 2002, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Sandy Cobian, Office Manager at the company’s single location by writing to 2727 West Baseline Road # 8, Tempe, Arizona AZ 85283 or by phoning (602) 323-0904. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Gila Internal Medicine |
Contact Person: | Sandy Cobian, Office Manager |
Address: | 2727 West Baseline Road # 8, Tempe, Arizona 85283 |
Phone Number: | (602) 323-0904 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2002 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Gila Internal Medicine was started in 2002 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Sandy Cobian, Office Manager for inquiries that concern Gila Internal Medicine by calling the company number (602) 323-0904, as your correspondence is most welcome. Additionally, the physical location of the single location of Gila Internal Medicine can be found at the coordinates 33.37815,-111.97697 as well as the street address 2727 West Baseline Road # 8 in Tempe, Arizona 85283.
For its online presence, you may visit Gila Internal Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.